Next Edge Biotech and Life Sciences Opp Fd Cl F1 (NEC217)
3.289
0.00 (0.00%)
CAD |
Aug 08 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.92% | -- | -- | 133.2% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -- | -29.82% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks short and long-term capital appreciation through the ownership of biotechnology and life sciences companies. Investments by the Fund may be made globally. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Alternative Long/Short Equity Global |
| Peer Group | Alternative Equity Focused |
| Global Macro | Alternative Equity |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Next Edge Capital |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
-81.99M
Peer Group Low
309.18M
Peer Group High
1 Year
% Rank:
--
-421.95M
Peer Group Low
3.794B
Peer Group High
3 Months
% Rank:
--
-220.61M
Peer Group Low
874.67M
Peer Group High
3 Years
% Rank:
--
-1.185B
Peer Group Low
8.440B
Peer Group High
6 Months
% Rank:
--
-254.45M
Peer Group Low
1.721B
Peer Group High
5 Years
% Rank:
--
-1.017B
Peer Group Low
9.058B
Peer Group High
YTD
% Rank:
--
-428.91M
Peer Group Low
3.003B
Peer Group High
10 Years
% Rank:
--
-234.91M
Peer Group Low
9.397B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 11, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 5000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks short and long-term capital appreciation through the ownership of biotechnology and life sciences companies. Investments by the Fund may be made globally. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Alternative Long/Short Equity Global |
| Peer Group | Alternative Equity Focused |
| Global Macro | Alternative Equity |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Next Edge Capital |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (8-8-25) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 0 |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | 12/31/2024 |
| Last Prospectus Date | -- |
| Share Classes | |
| NEC216 | Commission-based Advice |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:NEC217.TO", "name") |
| Broad Asset Class: =YCI("M:NEC217.TO", "broad_asset_class") |
| Broad Category: =YCI("M:NEC217.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:NEC217.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |